{"id":"W3141525584","doi":"10.60692/6p0fb-zvb10","title":"First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony","year":2009,"lang":"en","type":"article","venue":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Imiquimod; Placebo; Rash; Adverse effect; Dermatology; Cutaneous leishmaniasis; Internal medicine; Erythema; Randomized controlled trial; Surgery; Gastroenterology; Leishmaniasis; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008757881,0.0004889533,0.001096788,0.0003716284,0.0003313273,0.0002426177,0.0003584277,0.0004104185,0.001950987],"category_scores_gemma":[0.0006288658,0.000316739,0.0004393918,0.0002348392,0.0004384608,0.0002641192,0.0003135659,0.0006305072,0.0002702248],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002348461,"about_ca_system_score_gemma":0.000380726,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006127026,"about_ca_topic_score_gemma":0.001765713,"domain_scores_codex":[0.9997509,0.0001528386,0.00001328687,0.00002592388,0.00002508087,0.00003202299],"domain_scores_gemma":[0.99971,0.00007792418,0.00007745837,0.00002616738,0.00002645546,0.00008189704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2842345,0.0825449,0.0285163,0.004624062,0.001308178,0.0007994347,0.0006052091,0.0007792909,0.2729509,0.0002863294,0.001911268,0.3214397],"study_design_scores_gemma":[0.08481494,0.8070045,0.08305664,0.0002120536,0.00105186,0.0009745908,0.0001577195,0.0006904705,0.01789689,0.000121141,0.003991378,0.00002789102],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931006,0.004363113,0.0004067564,0.0002051996,0.00002863431,0.0009829525,0.0001056386,0.00003690993,0.0007700511],"genre_scores_gemma":[0.993804,0.003365674,0.000936673,0.0002132718,0.00009211356,0.0007828517,0.0002143971,0.000004499623,0.0005864177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001950987,"threshold_uncertainty_score":0.006526649,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0428423502709903,"score_gpt":0.3030157297021531,"score_spread":0.2601733794311628,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}